A carregar...

Memantine for dementia

BACKGROUND: Memantine is a moderate affinity uncompetitive antagonist of glutamate NMDA receptors. It is licensed for use in moderate and severe Alzheimer's disease (AD); in the USA, it is also widely used off‐label for mild AD. OBJECTIVES: To determine efficacy and safety of memantine for peop...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cochrane Database Syst Rev
Main Authors: McShane, Rupert, Westby, Maggie J, Roberts, Emmert, Minakaran, Neda, Schneider, Lon, Farrimond, Lucy E, Maayan, Nicola, Ware, Jennifer, Debarros, Jean
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2019
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6425228/
https://ncbi.nlm.nih.gov/pubmed/30891742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003154.pub6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!